Trump and RFK Jr outline health agenda that could reshape global policies

Donald Trump, the US President-elect, has announced a health agenda that may impact global health policies. He plans to work with Robert F. Kennedy Jr. to reform US health agencies, focusing on reducing corruption and improving scientific standards. Trump's proposals could affect international drug trade, as the US is a major market for European pharmaceuticals. Changes in US health policies, including potential cuts to the National Institutes of Health, may also shift clinical trials and drug development to Europe. Concerns are rising about increased vaccine skepticism in the US, which could influence attitudes in Europe. Trump's plans to revoke federal funding for states that mandate vaccinations may lead to lower immunization rates among American children, raising public health concerns.